Together Pharma Ltd
TGPHF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $91,006 | $31,228 | $12,026 | $11,223 |
| % Growth | 191.4% | 159.7% | 7.2% | – |
| Cost of Goods Sold | $56,384 | $37,116 | $14,199 | $17,062 |
| Gross Profit | $34,622 | -$5,888 | -$2,173 | -$5,839 |
| % Margin | 38% | -18.9% | -18.1% | -52% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $7,081 | $7,584 | $8,657 | $10,909 |
| SG&A Expenses | $12,528 | $11,611 | $10,990 | $11,287 |
| Sales & Mktg Exp. | $5,447 | $4,027 | $889 | $378 |
| Other Operating Expenses | $0 | -$2,270 | $0 | $0 |
| Operating Expenses | $12,528 | $13,420 | $9,029 | $11,156 |
| Operating Income | $22,094 | -$19,769 | -$11,457 | $16,630 |
| % Margin | 24.3% | -63.3% | -95.3% | 148.2% |
| Other Income/Exp. Net | -$20,555 | -$16,557 | -$3,659 | -$2,467 |
| Pre-Tax Income | $1,539 | -$36,326 | -$15,116 | $14,163 |
| Tax Expense | $4,073 | -$847 | $0 | -$1,310 |
| Net Income | -$4,316 | -$33,524 | -$13,776 | $7,152 |
| % Margin | -4.7% | -107.4% | -114.6% | 63.7% |
| EPS | -0.49 | -4.18 | -2.23 | 1.22 |
| % Growth | 88.3% | -87.4% | -282.8% | – |
| EPS Diluted | -0.49 | -4.11 | -2.01 | 1.24 |
| Weighted Avg Shares Out | 8,785 | 8,020 | 6,183 | 5,866 |
| Weighted Avg Shares Out Dil | 8,785 | 8,149 | 6,850 | 5,768 |
| Supplemental Information | – | – | – | – |
| Interest Income | $23,424 | $17,018 | $3,914 | $2,966 |
| Interest Expense | $0 | $17,036 | $14,870 | $11,867 |
| Depreciation & Amortization | $5,522 | $5,401 | $5,319 | $3,925 |
| EBITDA | $27,616 | -$14,368 | -$6,138 | $20,555 |
| % Margin | 30.3% | -46% | -51% | 183.2% |